Stock Market Projections Based on Genetic Algorithms: Returns up to 31.25% in 14 Days

Package Name: By Country - Australian Stocks
Recommended Positions: Long
Forecast Length: 14 Days (01/14/2019 - 01/28/2019)
I Know First Average: 9.65%

Read The Full Forecast

Stock Market Projections

Stock Analysis Based on Stock Algorithm: Returns up to 23.26% in 7 Days

Package Name: By Country - Australian Stocks
Recommended Positions: Long
Forecast Length: 7 Days (01/14/2019 - 01/21/2019)
I Know First Average: 6.38%

Read The Full Forecast

Stock Analysis

Australian Top Stocks Based on Big Data: Returns up to 18.75% in 3 Days

Package Name: By Country - Australian Stocks
Recommended Positions: Long
Forecast Length: 3 Days (01/13/2019 - 01/16/2019)
I Know First Average: 4.00%

Read The Full Forecast

Australian Top Stocks

Australian Stock Market Prediction Based on AI: Returns up to 24.30% in 3 Days

Package Name: By Country - Australian Stocks
Recommended Positions: Long
Forecast Length: 3 Days (11/06/2018 - 11/09/2018)
I Know First Average: 7.45%

Read The Full Forecast

Australian Stock Market Prediction

Australian Stock Market Forecasting Based on Artificial Intelligence: Returns up to 33.33% in 1 Month

Package Name: By Country - Australian Stocks
Recommended Positions: Long
Forecast Length: 1 Month (09/09/2018 - 10/09/2018)
I Know First Average: 6.10%

Read The Full Forecast

Australian Stock Market Forecasting

Winning Stocks Forecast: CUV.AX & YOW.AX bring highest returns from Australian stock market

Winning Stocks Forecast

Clinuvel Pharmaceuticals Limited (CUV.AX)

Source: biotech-capital.com

Over the past month Clinuvel Pharmaceuticals Limited (CUV.AX) saw a rise of 49.19% this marks it as the biggest earner within Australian Stock as I Know First predicted. This surge can be attributed to the anticipated FDA approval for its drug SCENESSE® a photo-protective drug used to treat a rare condition known as targeting erythropoietic protoporphyria (EPP). SCENESSE® is already approved by the EU in 2014 and was available from 2016 across Europe. In the first half of FY18, Clinuvel had revenue of just $7 million, enough to generate

Read More

Australian Stock Market Outlook Based on Pattern Recognition: Returns up to 51.58% in 1 Month

Package Name: By Country - Australian Stocks
Recommended Positions: Long
Forecast Length: 1 Month (09/07/2018 - 10/07/2018)
I Know First Average: 9.59%

Read The Full Forecast

Australian Stock Market Outlook
Pages:1234»